Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.32 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18852932 | 0.85 | KDM4E (0.35) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL26741876 | 0.84 | KDM4E (0.37) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL26742174 | 0.84 | ABCG2 (0.39) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL26741879 | 0.83 | KDM4E (0.36) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL20175785 | 0.83 | CA1 (0.35) | CYP1A2PTGER1PTGESCA1CA2 | |
| SCHEMBL26742202 | 0.83 | ABCG2 (0.34) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL18852817 | 0.82 | KDM4E (0.37) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL26741932 | 0.82 | ABCG2 (0.34) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL26742148 | 0.82 | CYP1A2 (0.34) | ABCG2CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL26741934 | 0.82 | ABCG2 (0.34) | ABCG2CYP1A1CYP1A2FYNMAPK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180141957-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180141957-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | ABCG2 4346/4885CYP1A1 582/4885CYP1A2 1359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.